These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29977339)

  • 41. Psychological Features in the Inflammatory Bowel Disease-Irritable Bowel Syndrome Overlap: Developing a Preliminary Understanding of Cognitive and Behavioral Factors.
    Petrik M; Palmer B; Khoruts A; Vaughn B
    Crohns Colitis 360; 2021 Jul; 3(3):otab061. PubMed ID: 36776665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
    Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome.
    von Arnim U; Wex T; Ganzert C; Schulz C; Malfertheiner P
    Clin Exp Gastroenterol; 2016; 9():97-103. PubMed ID: 27147826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
    Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
    Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anxiety, depression and quality of life in patients with irritable bowel syndrome.
    Cho HS; Park JM; Lim CH; Cho YK; Lee IS; Kim SW; Choi MG; Chung IS; Chung YK
    Gut Liver; 2011 Mar; 5(1):29-36. PubMed ID: 21461069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Low prevalence of 'classical' microscopic colitis but evidence of microscopic inflammation in Asian irritable bowel syndrome patients with diarrhoea.
    Hilmi I; Hartono JL; Pailoor J; Mahadeva S; Goh KL
    BMC Gastroenterol; 2013 May; 13():80. PubMed ID: 23651739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life.
    Böhn L; Störsrud S; Törnblom H; Bengtsson U; Simrén M
    Am J Gastroenterol; 2013 May; 108(5):634-41. PubMed ID: 23644955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis.
    Fairbrass KM; Costantino SJ; Gracie DJ; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1053-1062. PubMed ID: 33010814
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome.
    Ozdil K; Sahin A; Calhan T; Kahraman R; Nigdelioglu A; Akyuz U; Sokmen HM
    BMC Gastroenterol; 2011 Aug; 11():96. PubMed ID: 21880133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Irritable bowel syndrome: Epidemiology and risk factors in the adult Saudi population of the central region.
    Aljammaz KI; Alrashed AA; Alzwaid AA
    Niger J Clin Pract; 2020 Oct; 23(10):1414-1418. PubMed ID: 33047699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
    Nam K; Kim N; Song HJ; Baik GH; Choi SC; Kim HJ; Lee JY; Park KS; Park SY; Park SJ
    J Gastroenterol; 2021 Jun; 56(6):537-546. PubMed ID: 33687537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Depression and Structural Factors Are Associated With Symptoms in Patients of Irritable Bowel Syndrome With Diarrhea.
    Lu J; Shi L; Huang D; Fan W; Li X; Zhu L; Wei J; Fang X
    J Neurogastroenterol Motil; 2020 Sep; 26(4):505-513. PubMed ID: 32675388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation.
    Sood R; Camilleri M; Gracie DJ; Gold MJ; To N; Law GR; Ford AC
    Am J Gastroenterol; 2016 Oct; 111(10):1446-1454. PubMed ID: 27481310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Aliment Pharmacol Ther; 2014 Feb; 39(3):312-21. PubMed ID: 24308816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-Perceived Food Intolerances Are Common and Associated with Clinical Severity in Childhood Irritable Bowel Syndrome.
    Chumpitazi BP; Weidler EM; Lu DY; Tsai CM; Shulman RJ
    J Acad Nutr Diet; 2016 Sep; 116(9):1458-1464. PubMed ID: 27316779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Irritable Bowel Syndrome Symptoms in Nonalcoholic Fatty Liver Disease Patients Are an Indicator of Depression and Anxiety.
    Franco L; Jones-Pauley M; Tamimi O; Neshatian L; Nguyen D; Graviss E; Quigley EM; Victor D
    J Clin Gastroenterol; 2023 Nov-Dec 01; 57(10):1016-1023. PubMed ID: 36226999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Rome IV irritable bowel syndrome on work and activities of daily living.
    Goodoory VC; Ng CE; Black CJ; Ford AC
    Aliment Pharmacol Ther; 2022 Sep; 56(5):844-856. PubMed ID: 35794733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic review with meta-analysis: diagnostic overlap of microscopic colitis and functional bowel disorders.
    Guagnozzi D; Arias Á; Lucendo AJ
    Aliment Pharmacol Ther; 2016 Apr; 43(8):851-862. PubMed ID: 26913568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypnotherapy for Irritable Bowel Syndrome-Type Symptoms in Patients with Quiescent Inflammatory Bowel Disease: A Randomized, Controlled Trial.
    Hoekman DR; Vlieger AM; Stokkers PC; Mahhmod N; Rietdijk S; de Boer NK; de Meij TG; Frankenhuis C; D'Haens GR; Benninga MA
    J Crohns Colitis; 2021 Jul; 15(7):1106-1113. PubMed ID: 33245332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
    Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
    Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.